Paula Vieira-Martins

Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome

F. Petitprez, J. Halimi, E. Rondeau, 2019, Haematologica.

COVID-19 as a potential trigger of complement-mediated atypical HUS

S. Sadallah, G. Kaplanski, V. Frémeaux-Bacchi, 2021, Blood.

Defining the genetics of thrombotic microangiopathies.

V. Frémeaux-Bacchi, J. Rosain, Paula Vieira-Martins, 2016, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome.

J. Atkinson, M. Noris, C. Hue, 2015, Blood.

Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab.

R. Porcher, M. Robin, G. Socié, 2015, Blood.

Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies

C. Picard, M. Taha, V. Frémeaux-Bacchi, 2019, Front. Immunol..

Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy

G. Remuzzi, E. Volokhina, D. Gale, 2018, The Journal of Immunology.

Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.

N. Jourde-Chiche, J. Halimi, E. Rondeau, 2019, Kidney international.

Complement Gene Variants and Shiga Toxin-Producing Escherichia coli-Associated Hemolytic Uremic Syndrome: Retrospective Genetic and Clinical Study.

F. Weill, G. Deschênes, G. Roussey, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy

L. Kiger, E. Audureau, G. Bodivit, 2020, American journal of hematology.

Complement biomarkers as predictors of disease outcome in C3 glomerulopathy

Richard J. H. Smith, V. Frémeaux-Bacchi, L. Roumenina, 2018, Molecular Immunology.

Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab.

R. Porcher, M. Robin, G. Socié, 2015, Blood.

Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GN

E. Thervet, C. Dossier, N. Jourde-Chiche, 2023, Clinical journal of the American Society of Nephrology : CJASN.